The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
A cellular chemical probe targeting the chromodomains of Polycomb repressive complex 1
Open accessAbstract
We report the design and characterization of UNC3866, a potent antagonist of the methyl-lysine (Kme) reading function of the Polycomb CBX and CDY families of chromodomains. Polycomb CBX proteins regulate gene expression by targeting Polycomb Repressive Complex 1 to sites of H3K27me3 via their chromodomains. UNC3866 binds the chromodomains of CBX4 and CBX7 most potently with a Kd of ∼100 nM for each, and is 6- to 18-fold selective versus seven other CBX and CDY chromodomains while being highly selective versus >250 other protein targets. X-ray crystallography revealed that UNC3866 closely mimics the interactions of the methylated H3 tail with these chromodomains. UNC4195, a biotinylated derivative of UNC3866, was used to demonstrate that UNC3866 engages intact PRC1 and that EED incorporation into PRC1 is isoform-dependent in PC3 prostate cancer cells. Finally, UNC3866 inhibits PC3 cell proliferation, a known CBX7 phenotype, while UNC4219, a methylated negative control compound, has negligible effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047337 · Cited by 16,463
Selective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262
Epigenetic protein families: a new frontier for drug discovery
Arrowsmith, C. H., Bountra, C., Fish, P. V., Lee, K., & Schapira, M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3674 · Cited by 1,327
Self-citationAutomated design of ligands to polypharmacological profiles
Besnard, J., Ruda, G. F., Setola, V., Abecassis, K., Rodriguiz, R. M., Huang, X.-P., Norval, S., Sassano, M. F., Shin, A. I., Webster, L. A., et al. (2012) · Nature · doi:10.1038/nature11691 · Cited by 832
Self-citationTiwary, P., & Parrinello, M. (2013) · Physical Review Letters · doi:10.1103/physrevlett.111.230602 · Cited by 494
Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma
Hashizume, R., Andor, N., Ihara, Y., Lerner, R., Gan, H., Chen, X., Fang, D., Huang, X., Tom, M. W., Ngo, V., et al. (2014) · Nature Medicine · doi:10.1038/nm.3716 · Cited by 476
Self-citationKlauke, K., Radulović, V., Broekhuis, M., Weersing, E., Zwart, E., Olthof, S., Ritsema, M., Bruggeman, S., Wu, X., Helin, K., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2701 · Cited by 237
Morey, L., Aloia, L., Cozzuto, L., Benitah, S. A., & Di Croce, L. (2013) · Cell Reports · doi:10.1016/j.celrep.2012.11.026 · Cited by 201
Research works printed but not linked: 51
- Wagner, T., Robaa, D., Sippl, W. & Jung, M. Mind the methyl: methyllysine binding proteins in epigenetic regulation. ChemMedChem 9, 466–483 (2014). · DOI
- Kaustov, L. et al. Recognition and specificity determinants of the human cbx chromodomains. J. Biol. Chem. 286, 521–529 (2011). · DOI · Paper page
- Cao, Q. et al. The central role of EED in the orchestration of polycomb group complexes. Nat. Commun. 5, 3127 (2014). · DOI · Paper page
- Vandamme, J., Volkel, P., Rosnoblet, C., Le Faou, P. & Angrand, P.O. Interaction proteomics analysis of polycomb proteins defines distinct PRC1 complexes in mammalian cells. Mol. Cell Proteomics 10, M110.002642 (2011). · DOI
- Jin, B. et al. Linking DNA methyltransferases to epigenetic marks and nucleosome structure genome-wide in human tumor cells. Cell Rep. 2, 1411–1424 (2012). · DOI
- Eskeland, R. et al. Ring1B compacts chromatin structure and represses gene expression independent of histone ubiquitination. Mol. Cell 38, 452–464 (2010). · DOI · Paper page
- Bernard, D. et al. CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus. Oncogene 24, 5543–5551 (2005). · DOI
- Forzati, F. et al. CBX7 is a tumor suppressor in mice and humans. J. Clin. Invest. 122, 612–623 (2012). · DOI
- Shinjo, K. et al. Expression of chromobox homolog 7 (CBX7) is associated with poor prognosis in ovarian clear cell adenocarcinoma via TRAIL-induced apoptotic pathway regulation. Int. J. Cancer 135, 308–318 (2014). · DOI
- Mansueto, G. et al. Identification of a new pathway for tumor progression: microRNA-181b up-regulation and CBX7 down-regulation by HMGA1 protein. Genes Cancer 1, 210–224 (2010). · DOI
- Pallante, P. et al. Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancer. Cancer Res. 68, 6770–6778 (2008). · DOI
- Pallante, P. et al. The loss of the CBX7 gene expression represents an adverse prognostic marker for survival of colon carcinoma patients. Eur. J. Cancer 46, 2304–2313 (2010). · doi:10.1016/j.ejca.2010.05.011
- Karamitopoulou, E. et al. Loss of the CBX7 protein expression correlates with a more aggressive phenotype in pancreatic cancer. Eur. J. Cancer 46, 1438–1444 (2010). · DOI
- Zhang, X.W. et al. Oncogenic role of the chromobox protein CBX7 in gastric cancer. J. Exp. Clin. Cancer Res. 29, 114 (2010). · DOI
- Gil, J., Bernard, D., Martínez, D. & Beach, D. Polycomb CBX7 has a unifying role in cellular lifespan. Nat. Cell Biol. 6, 67–72 (2004). · DOI · Paper page
- Scott, C.L. et al. Role of the chromobox protein CBX7 in lymphomagenesis. Proc. Natl. Acad. Sci. USA 104, 5389–5394 (2007). · DOI · Paper page
- Tan, J. et al. CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis. Cancer Cell 20, 563–575 (2011). · DOI · Paper page
- Wang, B. et al. Chromobox homolog 4 is correlated with prognosis and tumor cell growth in hepatocellular carcinoma. Ann. Surg. Oncol. 20 (suppl. 3): S684–S692 (2013). · DOI
- Clermont, P.L. et al. Genotranscriptomic meta-analysis of the Polycomb gene CBX2 in human cancers: initial evidence of an oncogenic role. Br. J. Cancer 111, 1663–1672 (2014). · DOI
- Sauvageau, M. & Sauvageau, G. Polycomb group genes: keeping stem cell activity in balance. PLoS Biol. 6, e113 (2008). · DOI
- Konze, K.D. et al. An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1. ACS Chem. Biol. 8, 1324–1334 (2013). · DOI · Paper page
- Ntziachristos, P. et al. Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia. Nature 514, 513–517 (2014). · DOI · Paper page
- Simhadri, C. et al. Chromodomain antagonists that target the polycomb-group methyllysine reader protein chromobox homolog 7 (CBX7). J. Med. Chem. 57, 2874–2883 (2014). · DOI
- Ren, C. et al. Small-molecule modulators of methyl-lysine binding for the CBX7 chromodomain. Chem. Biol. 22, 161–168 (2015). · DOI
- Frye, S.V. The art of the chemical probe. Nat. Chem. Biol. 6, 159–161 (2010). · DOI · Paper page
- Bunnage, M.E., Chekler, E.L. & Jones, L.H. Target validation using chemical probes. Nat. Chem. Biol. 9, 195–199 (2013). · DOI · Paper page
- Workman, P. & Collins, I. Probing the probes: fitness factors for small molecule tools. Chem. Biol. 17, 561–577 (2010). · DOI · Paper page
- James, L.I. et al. Discovery of a chemical probe for the L3MBTL3 methyllysine reader domain. Nat. Chem. Biol. 9, 184–191 (2013). · DOI · Paper page
- Hopkinson, R.J. et al. Is JmjC oxygenase catalysis limited to demethylation? Angew. Chem. Int. Edn. Engl. 52, 7709–7713 (2013). · DOI
- Dickson, B.M. Approaching a parameter-free metadynamics. Phys. Rev. E 84, 037701 (2011). · DOI
- Muñoz, V., Thompson, P.A., Hofrichter, J. & Eaton, W.A. Folding dynamics and mechanism of β-hairpin formation. Nature 390, 196–199 (1997). · DOI · Paper page
- Xiao, Y., Chen, C. & He, Y. Folding mechanism of β-hairpin trpzip2: heterogeneity, transition state and folding pathways. Int. J. Mol. Sci. 10, 2838–2848 (2009). · doi:10.3390/ijms10062838
- Fischle, W., Franz, H., Jacobs, S.A., Allis, C.D. & Khorasanizadeh, S. Specificity of the chromodomain Y chromosome family of chromodomains for lysine-methylated ARK(S/T) motifs. J. Biol. Chem. 283, 19626–19635 (2008). · DOI
- Kroeze, W.K. et al. PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome. Nat. Struct. Mol. Biol. 22, 362–369 (2015). · DOI · Paper page
- Montgomery, N.D., Yee, D., Montgomery, S.A. & Magnuson, T. Molecular and functional mapping of EED motifs required for PRC2-dependent histone methylation. J. Mol. Biol. 374, 1145–1157 (2007). · DOI
- Kuzmichev, A., Jenuwein, T., Tempst, P. & Reinberg, D. Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3. Mol. Cell 14, 183–193 (2004). · DOI · Paper page
- Ren, X., Vincenz, C. & Kerppola, T.K. Changes in the distributions and dynamics of polycomb repressive complexes during embryonic stem cell differentiation. Mol. Cell. Biol. 28, 2884–2895 (2008). · DOI
- Martinez Molina, D. et al. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science 341, 84–87 (2013). · DOI · Paper page
- Li, Q. et al. Polycomb CBX7 directly controls trimethylation of histone H3 at lysine 9 at the p16 locus. PLoS One 5, e13732 (2010). · DOI
- Kong, Y., Cui, H., Ramkumar, C. & Zhang, H. Regulation of senescence in cancer and aging. J. Aging Res. 2011, 963172 (2011). · DOI
- Jarrard, D.F. et al. Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer. Genes Chromosom. Cancer 19, 90–96 (1997). · DOI · Paper page
- Yaqinuddin, A., Qureshi, S.A., Qazi, R. & Abbas, F. Down-regulation of DNMT3b in PC3 cells effects locus-specific DNA methylation, and represses cellular growth and migration. Cancer Cell Int. 8, 13 (2008). · doi:10.1186/1475-2867-8-13
- Yaqinuddin, A., Qureshi, S.A., Qazi, R., Farooq, S. & Abbas, F. DNMT1 silencing affects locus specific DNA methylation and increases prostate cancer derived PC3 cell invasiveness. J. Urol. 182, 756–761 (2009). · doi:10.1016/j.juro.2009.03.082
- Mirochnik, Y. et al. Androgen receptor drives cellular senescence. PLoS One 7, e31052 (2012). · DOI
- Hess, B., Kutzner, C., van der Spoel, D. & Lindahl, E. GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. J. Chem. Theory Comput. 4, 435–447 (2008). · DOI · Paper page
- Voter, A.F. Hyperdynamics: accelerated molecular dynamics of infrequent events. Phys. Rev. Lett. 78, 3908–3911 (1997). · DOI · Paper page
- Bussi, G., Donadio, D. & Parrinello, M. Canonical sampling through velocity rescaling. J. Chem. Phys. 126, 014101 (2007). · DOI · Paper page
- Wigle, T.J. et al. Screening for inhibitors of low-affinity epigenetic peptide-protein interactions: an AlphaScreen-based assay for antagonists of methyl-lysine binding proteins. J. Biomol. Screen. 15, 62–71 (2010). · DOI
- Perfetti, M.T. et al. Identification of a fragment-like small molecule ligand for the methyl-lysine binding protein, 53BP1. ACS Chem. Biol. 10, 1072–1081 (2015). · DOI
- Barsyte-Lovejoy, D. et al. (R)-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cells. Proc. Natl. Acad. Sci. USA 111, 12853–12858 (2014). · DOI · Paper page
- Evans, P.R. & Murshudov, G.N. How good are my data and what is the resolution? Acta Crystallogr. D Biol. Crystallogr. 69, 1204–1214 (2013). · DOI · Paper page
Cited by
Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer
Mohammad, H. P., Barbash, O., & Creasy, C. L. (2019) · Nature Medicine · doi:10.1038/s41591-019-0376-8 · Cited by 413
Lonati, E., Brambilla, A., Milani, C., Masserini, M., Palestini, P., & Bulbarelli, A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00001 · Cited by 347
Mechanisms of copper homeostasis in bacteria
Argüello, J. M., Raimunda, D., & Padilla-Benavides, T. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00073 · Cited by 297
Pathogenic adaptations to host-derived antibacterial copper
Chaturvedi, K. S., & Henderson, J. P. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2014.00003 · Cited by 134
Canonical PRC1 controls sequence-independent propagation of Polycomb-mediated gene silencing
Moussa, H. F., Bsteh, D., Yelagandula, R., Pribitzer, C., Stecher, K., Bartalska, K., Michetti, L., Wang, J., Zepeda-Martinez, J. A., Elling, U., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09628-6 · Cited by 75
Self-citation
Metadata
- Authors
- Stuckey, J. I., Dickson, B. M., Cheng, N., Liu, Y., Norris, J. L., Cholensky, S. H., Tempel, W., Qin, S., Huber, K. G., Sagum, C., Black, K., Li, F., Huang, X.-P., Roth, B. L., Baughman, B. M., Senisterra, G., Pattenden, S. G., Vedadi, M., Brown, P. J., Bedford, M. T., Min, J., Arrowsmith, C. H., James, L. I., & Frye, S. V.
- Venue
- Nature Chemical Biology
- Published
- 2016-01-25
- Volume
- 12
- Issue
- 3
- Pages
- 180-187
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- OpenAlex
- W2270756322
- Cited by
- 225
- References
- 9
- FWCI
- 12.04
- Type
- journal article
- Language
- en
- Update notices
- addendum (2019-03-06)
- Open access
- green
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A cellular chemical probe targeting the chromodomains of Polycomb repressive complex 1. https://app.cochat.ai/papers/10.1038/nchembio.2007
- The paper
- Stuckey, J. I., Dickson, B. M., Cheng, N., Liu, Y., Norris, J. L., Cholensky, S. H., Tempel, W., Qin, S., Huber, K. G., Sagum, C., Black, K., Li, F., Huang, X.-P., Roth, B. L., Baughman, B. M., Senisterra, G., Pattenden, S. G., Vedadi, M., Brown, P. J., . . . Frye, S. V. (2016). A cellular chemical probe targeting the chromodomains of Polycomb repressive complex 1. Nature Chemical Biology. https://doi.org/10.1038/nchembio.2007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.